Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Mochida

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Mochida's Japan sales performance.

BMS scores first oesophageal cancer nod for Opdivo in Japan

BMS scores first oesophageal cancer nod for Opdivo in Japan

Approval in Japan comes before US okay. Bristol-Myers Squibb has won its first approval for Opdivo in oesophageal cancer, with an approval in Japan coming before a nod in the ... US. . Japan’s Ministry of Health, Labor and Welfare (MHLW) approved

Incyte’s JAK inhibitor cream clears second eczema trial

Incyte’s JAK inhibitor cream clears second eczema trial Incyte has said it intends to market ruxolitinib cream itself in the US if approved, but may seek partnerships in other territories such as Europe and Japan.

Pfizer’s Vyndaqel is first EU therapy for ATTR cardiomyopathy

Pfizer’s Vyndaqel is first EU therapy for ATTR cardiomyopathy The drug has also been approved for the cardiomyopathy indication in Japan, Brazil and Canada.

FDA sets Q3 decision date for NS Pharma’s DMD drug

FDA sets Q3 decision date for NS Pharma’s DMD drug phase 1/2 study in Japan. ... NS Pharma and its parent company Nippon Shinyaku are currently enrolling patients for a phase 3 study in Japan and the US – named RACER53.

China’s BrightGene successfully copies Gilead’s coronavirus hopeful remdesivir

China’s BrightGene successfully copies Gilead’s coronavirus hopeful remdesivir A Chinese state-owned news agency – Xinhua – has reported that trials have already officially launched, following the approval by China’s National Medical Products Administration of applications by the China-Japan

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Red Health

Red Health was formed in 2007 to bring something fresh to the healthcare PR world. Our approach was simple –...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics